Sign in now to see personalised content appear here.
You can also see your reading history and subscription details on your subscriber page.
With its recent acquisitions the company has a rapidly growing portfolio of analytical solutions for pharma and biopharma applications
Provides moisture, oxygen and vapour barrier properties approaching those of aluminium foil
Former AstraZeneca serialisation expert Christoph Krähenbühl demystifies the arguments around compliance with the forthcoming Safety Features regulations in the EU Falsified Medicines Directive, and questions whether some countries are dangerously behind in their implementation strategies
Vaccine candidate was developed by researchers at the Public Health Agency of Canada’s National Microbiology Laboratory
Features a compact design and lockable castors
There has been considerable progress in the application of single-use technologies in biopharmaceutical production. CMO Rentschler Biotechnologie discusses recent advances
University of Leicester academic leads study into effects of cediranib drug in chemotherapy treatment of cervical cancer
Armin Dalluege, General Manager of Wasserburger Arzneimittelwerk, a subsidiary of Recipharm, in Wasserburg, Germany, highlights trends in drug lyophilisation
For comparing multiple drugs in a single living tumour
With an increase in the number of innovator companies looking to outsource the development and manufacture of mPEGs, Dr. Reddy’s (CPS) discusses what to look for in a potential outsourcing partner
Rapid scientific advice to speed up development
With regulatory pressure mounting, pharma companies should need no help deciding to migrate to paperless trial master files. For those thinking about switching, Rik van Mol, Vice President of R&D Strategy, Veeva Systems, outlines the key considerations for making the transition